Segments - Operations and Assets Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Jan. 01, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Total revenues	$ 329,219	$ 545,165
Operating income (loss)	(72,424)	38,437
Depreciation and amortization	27,814	19,989
Loss from investment in investees	(49)	(43)
Assets	2,306,858			$ 2,399,715
Goodwill	519,052		$ 710,408	520,601
United States
Segment Reporting Information [Line Items]
Total revenues	291,808	512,871
Ireland
Segment Reporting Information [Line Items]
Total revenues	8,462	7,129
Chile
Segment Reporting Information [Line Items]
Total revenues	16,339	14,152
Spain
Segment Reporting Information [Line Items]
Total revenues	7,109	5,919
Israel
Segment Reporting Information [Line Items]
Total revenues	1,558	2,512
Mexico
Segment Reporting Information [Line Items]
Total revenues	3,750	2,418
Other
Segment Reporting Information [Line Items]
Total revenues	193	164
Corporate
Segment Reporting Information [Line Items]
Operating income (loss)	(10,768)	(9,420)
Depreciation and amortization	0	0
Loss from investment in investees	0	0
Assets	55,052			46,672
Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)	(18,108)	(19,157)
Depreciation and amortization	15,402	7,413
Loss from investment in investees	(49)	(43)
Assets	1,099,633			1,114,460
Goodwill	236,028			237,576
Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)	(43,548)	67,014
Depreciation and amortization	12,412	12,576
Loss from investment in investees	0	0
Assets	1,152,173			1,238,583
Goodwill	283,024			$ 283,025
Services
Segment Reporting Information [Line Items]
Total revenues	286,599	506,951
Services | Corporate
Segment Reporting Information [Line Items]
Total revenues	0	0
Services | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	0	0
Services | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	286,599	506,951
Products
Segment Reporting Information [Line Items]
Total revenues	36,658	33,945
Products | Corporate
Segment Reporting Information [Line Items]
Total revenues	0	0
Products | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	36,658	33,945
Products | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	0	0
Transfer of intellectual property and other
Segment Reporting Information [Line Items]
Total revenues	5,962	4,269
Transfer of intellectual property and other | Corporate
Segment Reporting Information [Line Items]
Total revenues	0	0
Transfer of intellectual property and other | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	5,962	4,269
Transfer of intellectual property and other | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	$ 0	$ 0